Company / Cost of Revenue
Glaukos Corp. Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$111.8M
FY2025
5-year range
$38.6M / $111.8M
FY2021-FY2025
Trend
+18.9%
vs FY2024
Sector context
#91 of 113
Health Care
What the data says
Glaukos Corp.'s cost of revenue of $112M is lower than 81% of companies in the Health Care sector (FY2025). Cost of Revenue has fluctuated over the past 10 years, ranging from $13M in FY2017 to $112M in FY2025.
Based on SEC 10-K filings.
$112M in FY2025 with a 5-year CAGR of +34.9%.
Increased from $67M to $112M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +6.8%
- 5-Year CAGR
- +34.9%
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 113This company $111.8M Sector average $11.3B
▼
-99.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +34.9%, indicating consistent growth.
- In FY2025, cost of revenue increased 18.9% year-over-year.
- Ranks #91 out of 113 companies in the Health Care sector.
- Lowest cost of revenue in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $111.8M | +18.9% |
| FY2024 | $94.0M | +41.1% |
| FY2023 | $66.6M | -27.4% |
| FY2022 | $91.7M | +137.7% |
| FY2021 | $38.6M | +53.9% |
| FY2020 | $25.1M | +19.1% |
| FY2019 | $21.1M | +30.1% |
| FY2018 | $16.2M | +24.6% |
| FY2017 | $13.0M | -19.7% |
| FY2016 | $16.2M | +538.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026